Author:
Netherton Tucker J.,Cardenas Carlos E.,Rhee Dong Joo,Court Laurence E.,Beadle Beth M.
Abstract
<b><i>Background:</i></b> The future of artificial intelligence (AI) heralds unprecedented change for the field of radiation oncology. Commercial vendors and academic institutions have created AI tools for radiation oncology, but such tools have not yet been widely adopted into clinical practice. In addition, numerous discussions have prompted careful thoughts about AI’s impact upon the future landscape of radiation oncology: How can we preserve innovation, creativity, and patient safety? When will AI-based tools be widely adopted into the clinic? Will the need for clinical staff be reduced? How will these devices and tools be developed and regulated? <b><i>Summary:</i></b> In this work, we examine how deep learning, a rapidly emerging subset of AI, fits into the broader historical context of advancements made in radiation oncology and medical physics. In addition, we examine a representative set of deep learning-based tools that are being made available for use in external beam radiotherapy treatment planning and how these deep learning-based tools and other AI-based tools will impact members of the radiation treatment planning team. <b><i>Key Messages:</i></b> Compared to past transformative innovations explored in this article, such as the Monte Carlo method or intensity-modulated radiotherapy, the development and adoption of deep learning-based tools is occurring at faster rates and promises to transform practices of the radiation treatment planning team. However, accessibility to these tools will be determined by each clinic’s access to the internet, web-based solutions, or high-performance computing hardware. As seen by the trends exhibited by many technologies, high dependence on new technology can result in harm should the product fail in an unexpected manner, be misused by the operator, or if the mitigation to an expected failure is not adequate. Thus, the need for developers and researchers to rigorously validate deep learning-based tools, for users to understand how to operate tools appropriately, and for professional bodies to develop guidelines for their use and maintenance is essential. Given that members of the radiation treatment planning team perform many tasks that are automatable, the use of deep learning-based tools, in combination with other automated treatment planning tools, may refocus tasks performed by the treatment planning team and may potentially reduce resource-related burdens for clinics with limited resources.
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Rattan R, Kataria T, Banerjee S, Goyal S, Gupta D, Pandita A, et al. Artificial intelligence in oncology, its scope and future prospects with specific reference to radiation oncology. BJR Open. 2019 Jul 14;1(1):20180031.
2. Boon I, Au Yong T, Boon C. Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation. Medicines. 2018 Dec 11;5(4):131.
3. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, et al. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?Radiother Oncol. 2018;129:421–6.
4. Kiser KJ, Fuller CD, Reed VK. Artificial intelligence in radiation oncology treatment planning: a brief overview. J Med Artif Intell. 2019;2:9.
5. Beam AL, Kohane IS. Translating artificial intelligence into clinical care. JAMA. 2016;316:2368–9.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献